Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Change in Cash: 2019-2021

Historic Change in Cash for Burning Rock Biotech (BNR) over the last 2 years, with Dec 2021 value amounting to -$76.0 million.

  • Burning Rock Biotech's Change in Cash fell 127.60% to -$76.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$119.2 million, marking a year-over-year decrease of 121.61%. This contributed to the annual value of -$12.7 million for FY2024, which is 70.81% up from last year.
  • Per Burning Rock Biotech's latest filing, its Change in Cash stood at -$76.0 million for Q4 2021, which was down 109.68% from -$36.2 million recorded in Q3 2021.
  • Over the past 5 years, Burning Rock Biotech's Change in Cash peaked at $310.7 million during Q2 2020, and registered a low of -$76.0 million during Q4 2021.
  • Over the past 3 years, Burning Rock Biotech's median Change in Cash value was $408,624 (recorded in 2019), while the average stood at $48.1 million.
  • In the last 5 years, Burning Rock Biotech's Change in Cash surged by 67,292.08% in 2020 and then tumbled by 127.60% in 2021.
  • Burning Rock Biotech's Change in Cash (Quarterly) stood at $408,624 in 2019, then soared by 67,292.08% to $275.4 million in 2020, then plummeted by 127.60% to -$76.0 million in 2021.
  • Its Change in Cash was -$76.0 million in Q4 2021, compared to -$36.2 million in Q3 2021 and -$35.6 million in Q2 2021.